CV Therapeutics (CVTX) option implied volatility indicates Risk into Merlin Trial Data
Tweet Send to a Friend
CV Therapeutics (Nasdaq: CVTX) : CVTX's MERLIN trail data results for Ranexa, a treatment for refractory angina, will ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
